e-learning
resources
Vienna 2009
Monday, 14.09.2009
Systemic consequences of sleep-disordered breathing
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Does obstructive sleep apnoea predispose to reduced renal function?
R. Damodhar, D. Narasimhiah, M. Sivalingam, K. Farrington, I. Chakravorty (Stevenage, United Kingdom)
Source:
Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Session:
Systemic consequences of sleep-disordered breathing
Session type:
E-Communication Session
Number:
2832
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Damodhar, D. Narasimhiah, M. Sivalingam, K. Farrington, I. Chakravorty (Stevenage, United Kingdom). Does obstructive sleep apnoea predispose to reduced renal function?. Eur Respir J 2009; 34: Suppl. 53, 2832
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Related content which might interest you:
Evaluation of renal function in a cohort of patients affected by obstructive sleep apnea
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
A comparison of pulmonary function, functional exercise capacity and sleep quality in patients with chronic obstructive pulmonary disease and obstructive sleep apnea syndrome
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012
Can obstructive sleep apnea (OSA) affect the evolution of pulmonary fibrosis? A description of cases
Source: Eur Respir J 2007; 30: Suppl. 51, 121s
Year: 2007
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Markers of liver dysfunction in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
Renal impairment: potentially under-stated in patients with obstructive sleep apnoea
Source: Eur Respir J 2007; 30: Suppl. 51, 592s
Year: 2007
Treating obstructive sleep apnoea to improve control of hypertension
Source: International Congress 2014 – ERS/JAMA lunchtime session: 2014 highlights
Year: 2014
Changes in baroreflex activity in obstructive sleep apnea: cause or consequence?
Source: Eur Respir J 2007; 30: Suppl. 51, 748s
Year: 2007
Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007
The effect of concomitant COPD on obstructive sleep apnea syndrome severity and sleep structure
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
The impact of obstructive sleep apnoea syndrome on endothelial function in patients with moderate and severe hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 39s
Year: 2005
Can leptin be used to treat obstructive sleep apnoea?
Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside
Year: 2019
Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease
Source: Eur Respir J 2013; 41: 616-620
Year: 2013
Treatment of obstructive and central sleep apnoea in heart failure: practical options
Source: Eur Respir Rev 2007; 16: 183-188
Year: 2007
Nocturnal hypoxia as an additional factor of functional kidney damage in patients with obstructive sleep apnoea syndrome
Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea
Year: 2008
Clinical phenotypes in patients with concomitant obstructive sleep apnea and chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012
The metabolic consequences of obstructive sleep apnoea in children
Source: Breathe 2009; 6: 111-114
Year: 2009
Prevalence of obstructive airway disease in patients with obstructive sleep apnea
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012
Impaired work productivity in obstructive sleep apnea patients
Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept